Latest Insider Transactions at Lyell Immunopharma, Inc. (LYEL)
This section provides a real-time view of insider transactions for Lyell Immunopharma, Inc. (LYEL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Lyell Immunopharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Lyell Immunopharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2021
|
Glaxosmithkline PLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
30,253,189
+50.0%
|
-
|